What does it mean to have a lack of Hill grade III on an upper endoscopy (esophagogastroduodenoscopy)?

Hill Grade III on Upper Endoscopy: Moderate Gastroesophageal Junction Dysfunction

A Hill grade III finding on EGD indicates moderate impairment of the gastroesophageal flap valve (GEFV), where the valve is barely visible and fails to close around the endoscope, representing an intermediate stage of anti-reflux barrier disruption that significantly increases risk for gastroesophageal reflux disease (GERD). 1

Understanding the Hill Classification

The Hill classification grades the gastroesophageal flap valve at the junction between the esophagus and stomach on a 4-point scale 1:

• Grade 1: Prominent fold of tissue closely apposed to the endoscope (normal)
• Grade 2: Valve present but transiently opens/closes with respiration (mild dysfunction)
• Grade 3: Valve barely visible, fails to close around endoscope (moderate dysfunction)
• Grade 4: Valve completely absent, junction continuously open, hiatal hernia always present (severe dysfunction)

Clinical Significance of Hill Grade III

Hill grade III represents a clinically meaningful threshold where GERD risk substantially increases. The evidence demonstrates:

• In PPI-naïve patients, Hill grade III is independently associated with esophagitis (adjusted OR 2.20) and need for ongoing PPI therapy (adjusted OR 1.95) 2
• After bariatric surgery, preoperative Hill grade III-IV independently predicts postoperative GERD (adjusted OR 3.92) 3 and remains predictive even after adjusting for hiatal hernia 4
• Meta-analysis data shows abnormal GEFV (grades III-IV) confers 1.88-fold increased risk of symptomatic GERD and 2.17-fold increased risk of erosive esophagitis 5

What This Means for Patient Management

According to AGA guidelines, complete endoscopic GERD evaluation should include Hill grading of the flap valve 6. When Hill grade III is identified:

Immediate Implications:

1. Higher index of suspicion for GERD - Even without visible esophagitis, the compromised anti-reflux barrier increases likelihood of pathologic acid exposure
2. Consider objective reflux testing - If symptoms persist despite PPI therapy, prolonged wireless pH monitoring (96-hour preferred) off medication should be performed to confirm GERD 6
3. Anticipate need for ongoing therapy - Hill grade III patients are more likely to require chronic acid suppression 2

Treatment Approach:

• Initial management: 4-8 week trial of single-dose PPI therapy if symptomatic 6
• If inadequate response: Increase to twice-daily dosing or switch to more potent acid suppressive agent 6
• Long-term considerations: At 12 months, evaluate appropriateness of continued PPI therapy with endoscopy and reflux monitoring off PPI 6

Important Caveats

The distinction between Hill grades I and II lacks clinical significance - research shows no meaningful difference in GERD outcomes between these grades 2. However, the threshold between grades II and III is clinically important, marking transition to pathologic anti-reflux barrier dysfunction.

Hill grade III does not automatically mean GERD is present - it indicates structural vulnerability. Correlation with symptoms, esophagitis findings (Los Angeles classification), and objective reflux testing determines actual GERD diagnosis 6.

Newer classification systems may offer advantages - The American Foregut Society (AFS) classification, which incorporates hiatal hernia length, hiatal opening diameter, and flap valve assessment, demonstrates superior interobserver agreement (ICC 0.749 vs 0.651) and better GERD prediction compared to Hill classification alone 7, 8.

Practical Algorithm

For a patient with Hill grade III on EGD:

1. Document associated findings: Hiatal hernia size, esophagitis grade (Los Angeles), Barrett's esophagus 1, 6
2. If symptomatic without erosive disease (LA grade B or higher): Initiate PPI trial and reassess at 4-8 weeks 6
3. If symptoms persist on PPI: Perform prolonged wireless pH monitoring off PPI to confirm GERD 6
4. If confirmed GERD with ongoing symptoms: Consider precision management based on reflux phenotype, including adjunctive therapies or anti-reflux procedures in selected cases 6
5. If asymptomatic: No immediate treatment required, but maintain awareness of increased GERD risk for future symptom development

The presence of Hill grade III should prompt thorough evaluation and lower threshold for objective testing, as it represents measurable anti-reflux barrier compromise that predicts future GERD complications and treatment needs 2, 5, 3, 4.